Overview
For patients diagnosed with low or ultra-low rectal cancer, one of the most critical questions is whether a permanent colostomy can be avoided. Advances in minimally invasive surgical technique — particularly robotic surgery and intersphincteric resection (ISR) — have made sphincter preservation possible for many patients who would previously have required a permanent stoma. Shanghai's leading rectal cancer surgeons are among the most experienced in Asia for these complex, function-preserving procedures.
China Medical Concierge Shanghai (CMCS) connects international patients with Shanghai's top colorectal cancer surgeons, including specialists in ultra-low rectal cancer and sphincter-preserving surgery.
Understanding Rectal Cancer
What Is Rectal Cancer?
Rectal cancer develops in the rectum — the final 12–15 cm of the large intestine before the anus. It is a subtype of colorectal cancer and shares many risk factors, but requires distinct surgical planning due to its proximity to the anal sphincter, pelvic nerves, and surrounding structures. Treatment of rectal cancer — particularly low and ultra-low tumors — demands a high level of surgical specialization.
Common Symptoms
- Rectal bleeding or blood in stool
- Change in bowel habits (frequency, consistency, or urgency)
- Feeling of incomplete bowel emptying (tenesmus)
- Rectal pain or pressure
- Unexplained weight loss and fatigue
- Anaemia
Risk Factors
- Age over 50
- Personal or family history of colorectal cancer or polyps
- Inflammatory bowel disease
- High-fat, low-fiber diet; red and processed meat consumption
- Obesity, sedentary lifestyle, smoking, and heavy alcohol use
- Hereditary syndromes (Lynch syndrome, FAP)
Diagnosis & Staging for Rectal Cancer
Precise staging is especially critical for rectal cancer, as it directly determines whether sphincter preservation is feasible:
- Colonoscopy with biopsy — definitive diagnosis
- MRI of the pelvis — the gold standard for rectal cancer staging; assesses tumor distance from the anal sphincter, mesorectal fascia involvement, and lymph node status
- CT scan (chest/abdomen/pelvis) — distant metastasis staging
- Endoscopic ultrasound (EUS) — T-staging for early rectal cancer
- Molecular profiling — RAS/RAF, MSI/MMR, HER2 for systemic therapy planning
Treatment Options: Sphincter Preservation & Robotic Surgery
Intersphincteric Resection (ISR) — Sphincter-Preserving Surgery for Ultra-Low Rectal Cancer
ISR (Intersphincteric Resection / 括约肌间切除术) is a technically demanding surgical procedure that allows curative resection of ultra-low rectal tumors — those located within 1–3 cm of the anal verge — while preserving the external anal sphincter and avoiding a permanent colostomy. ISR requires exceptional surgical precision and is only performed by highly experienced colorectal surgeons at specialist centers.
For international patients facing a diagnosis of low or ultra-low rectal cancer, access to an ISR-experienced surgeon can be life-changing — preserving bowel function and quality of life without compromising oncological outcomes.
Da Vinci Robotic Surgery
The da Vinci robotic surgical system offers significant advantages for rectal cancer surgery, particularly in the narrow confines of the male pelvis. Robotic assistance provides:
- Enhanced 3D visualization and magnification
- Greater instrument precision and range of motion in confined spaces
- Improved nerve preservation (reducing risk of urinary and sexual dysfunction)
- Reduced blood loss and faster recovery compared to open surgery
Robotic ISR — combining the precision of robotic assistance with the complexity of sphincter-preserving resection — represents the current frontier of rectal cancer surgery.
Laparoscopic Colorectal Surgery
For colorectal cancers not requiring ISR, laparoscopic (keyhole) surgery remains the standard minimally invasive approach, offering equivalent oncological outcomes to open surgery with faster recovery and reduced complications.
Multidisciplinary Team (MDT) Approach
Complex colorectal and gastric cancer cases — including locally advanced, recurrent, or metastatic disease — are best managed through a multidisciplinary tumor board (MDT), where surgery, medical oncology, radiation oncology, radiology, and pathology collaborate to develop the optimal individualized treatment plan.
Neoadjuvant Chemoradiotherapy for Rectal Cancer
For locally advanced rectal cancer (T3–T4 or node-positive), neoadjuvant chemoradiotherapy (preoperative radiation combined with chemotherapy) is used to shrink the tumor before surgery, improving resectability and potentially enabling sphincter preservation in cases where it would otherwise not be feasible.
Why Choose Shanghai for Rectal Cancer Surgery?
- ISR expertise — Shanghai surgeons are among Asia's most experienced in sphincter-preserving surgery for ultra-low rectal cancer
- Da Vinci robotic surgery — robotic-assisted rectal resection routinely performed at leading centers
- MDT-based complex case management — multidisciplinary tumor boards for locally advanced and recurrent disease
- Military medical center precision — Changzheng Hospital combines military-grade surgical standards with civilian oncology innovation
- Cost-effective world-class care — significantly lower cost than equivalent treatment in the US, UK, or Singapore
Featured Specialist: Dr. Wang Zhiguo — Changzheng Hospital (Naval Medical University)
Dr. Wang Zhiguo (王治国) is an Associate Chief Physician of Gastrointestinal Surgery at Changzheng Hospital (The Second Affiliated Hospital of Naval Medical University) — one of Shanghai's major military-affiliated academic medical centers.
Clinical Expertise
- ISR (Intersphincteric Resection) for ultra-low rectal cancer — sphincter-preserving surgery for tumors within 1–3 cm of the anal verge, avoiding permanent colostomy
- Da Vinci robotic surgery — certified robotic surgeon (da Vinci primary surgeon qualification) for colorectal and gastric cancer resections
- Laparoscopic minimally invasive surgery — laparoscopic colectomy and rectal resection
- MDT comprehensive treatment for complex GI tumors — multidisciplinary management of locally advanced, recurrent, and metastatic colorectal and gastric cancer
Sphincter Preservation: A Life-Changing Specialty
Dr. Wang's particular expertise in ISR for ultra-low rectal cancer addresses one of the most emotionally and functionally significant challenges in colorectal cancer surgery. For patients who have been told elsewhere that a permanent colostomy is unavoidable, a consultation with Dr. Wang may reveal that sphincter-preserving surgery is in fact possible — with equivalent oncological safety.
For international patients, Dr. Wang's team offers remote pre-consultation review of MRI, colonoscopy reports, and pathology, enabling a precise assessment of sphincter preservation feasibility before arrival in Shanghai.
How CMCS Supports Your Journey
CMCS is not a hospital — we are your dedicated medical concierge, providing a trusted bridge between international patients and Shanghai's finest cancer specialists.
Our services include:
- ✅ Direct appointment coordination with Dr. Wang Zhiguo and other top rectal cancer specialists at Changzheng Hospital
- ✅ MRI and colonoscopy report translation and remote sphincter-preservation feasibility assessment
- ✅ Second opinion facilitation — especially for patients seeking alternatives to permanent colostomy
- ✅ Hospital admission and surgical scheduling support
- ✅ Accommodation and logistics coordination in Shanghai
- ✅ Post-treatment follow-up and remote check-in support
Contact CMCS
If you or a loved one has been diagnosed with low or ultra-low rectal cancer and would like to explore sphincter-preserving surgery options in Shanghai, our team is ready to help.
📧 Email: contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 Website: www.medicalsh.com
CMCS — China Medical Concierge Shanghai. Connecting international patients with Shanghai's finest specialists.
0 Kommentare